⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144473 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL15152253 | 0.71 | — | — | |
| SCHEMBL21926752 | 0.67 | — | — | |
| SCHEMBL19053 | 0.66 | — | — | |
| Formaldehyde SCHEMBL8466585 | 0.62 | — | — | |
| SCHEMBL13213076 | 0.62 | — | — | |
| Glycine SCHEMBL1148008 | 0.62 | — | — | |
| SCHEMBL14513778 | 0.62 | — | — | |
| Hydrogen Peroxide SCHEMBL4288872 | 0.61 | — | — | |
| Bromide SCHEMBL10644201 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024127333-A1 | CYTOTOXIC COMPOUNDS | PHEON THERAPEUTICS LTD (GB) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024127332-A1 | CYTOTOXIC COMPOUNDS | PHEON THERAPEUTICS LTD (GB) | 2024-06-20 | — | — | WO | disclosed |
| EP-4188927-A1 | CYTOTOXIC AGENTS | Pheon Therapeutics Ltd (GB) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022023735-A1 | CYTOTOXIC AGENTS | FEMTOGENIX LIMITED (GB) | 2022-02-03 | — | — | WO | disclosed |
| EP-3917924-A1 | G-A CROSSLINKING CYTOTOXIC AGENTS | Femtogenix Limited (GB) | 2021-12-08 | — | — | EP | disclosed |
| EP-3847166-A1 | POLYCYCLIC AMIDES AS CYTOTOXIC AGENTS | Femtogenix Limited (GB) | 2021-07-14 | — | — | EP | disclosed |
| WO-2020157491-A1 | G-A CROSSLINKING CYTOTOXIC AGENTS | FEMTOGENIX LIMITED (GB) | 2020-08-06 | — | — | WO | disclosed |
| WO-2020152462-A1 | PYRROLOBENZODIAZEPINE DERIVATIVES AS INHIBITORS OF NF-KAPPA B FOR THE TREATMENT OF PROLIFERATIVE DISEASES | KING'S COLLEGE LONDON (GB) | 2020-07-30 | — | — | WO | disclosed |
| EP-3679045-A1 | CYTOTOXIC AGENTS | Femtogenix Limited (GB) | 2020-07-15 | — | — | EP | disclosed |
| EP-3455225-A1 | ASYMMETRIC CONJUGATE COMPOUNDS | Femtogenix Limited (GB) | 2019-03-20 | — | — | EP | disclosed |
| WO-2019043417-A1 | CYTOTOXIC AGENTS | FEMTOGENIX LIMITED (GB) | 2019-03-07 | — | — | WO | disclosed |
| EP-3386985-A1 | PBD ANTIBACTERIAL AGENTS | Kings College London (GB) | 2018-10-17 | — | — | EP | disclosed |
| EP-3337795-A1 | PIPERIDINOBENZODIAZEPINE COMPOUNDS WITH ANTI PROLIFERATIVE ACTIVITY | Femtogenix Limited (GB) | 2018-06-27 | — | — | EP | disclosed |
| EP-3307743-A1 | PDD AND BPD COMPOUNDS | Femtogenix Limited (GB) | 2018-04-18 | — | — | EP | disclosed |
| WO-2017194960-A1 | ASYMMETRIC CONJUGATE COMPOUNDS | FEMTOGENIX LIMITED (GB) | 2017-11-16 | — | — | WO | disclosed |
| WO-2017098257-A1 | PBD ANTIBACTERIAL AGENTS | KING'S COLLEGE LONDON (GB) | 2017-06-15 | — | — | WO | disclosed |
| WO-2017032983-A1 | PIPERIDINOBENZODIAZEPINE COMPOUNDS WITH ANTI PROLIFERATIVE ACTIVITY | FEMTOGENIX LIMITED (GB) | 2017-03-02 | — | — | WO | disclosed |
| WO-2016198869-A1 | PDD AND BPD COMPOUNDS | FEMTOGENIX LIMITED (GB) | 2016-12-15 | — | — | WO | disclosed |
| WO-2015166289-A1 | PYRROLOBENZODIAZEPINE COMPOUNDS | FEMTOGENIX LIMITED (GB) | 2015-11-05 | — | — | WO | disclosed |